Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Isolation and Characterization of Donor-Derived Exosomes in Human Lung Transplantation

FY 2018-19

Summary
Although lung transplantation is the best strategy for the treatment of patients with lung failure, post-transplant survival is limited to a median of 6 years. This is largely due to the development of chronic lung allograft dysfunction (CLAD), a condition resulting from the body's attack on the foreign donor lung. Because current treatment strategies for CLAD are minimally effective and are associated with numerous side effects, there is need for better therapeutic options. To resolve this need, my study aims at enhancing our understanding of the mechanism underlying the development of CLAD through the analysis of exosomes. Exosomes are small fluid-filled sacs released by most cells of the body. They contain proteins and other molecules that carry information from their cell of origin to neighboring cells. In particular, immune cells responsible for fighting off bacteria and foreign objects in the body release exosomes containing proteins involved in immune activation. This activation could in turn increase the production of exosomes, thus perpetuating injury. Therefore, I predict that exosomes released by donor lungs are present in recipients, and they stimulate immune response which leads to CLAD. To test this, I will isolate and identify donor exosomes from three biological fluids: wash of donor lung outside the body, wash of donor lung after transplantation, and patient’s blood. Then, I will analyze the quantity and quality of donor exosomes in each body fluid, and see how these correlate with patient outcome. If CLAD patients present with an altered donor exosome profile compared to stable patients, then this suggests that exosomes may play a role in CLAD development, and treatments strategies may be adjusted accordingly.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
406570
Name
Madu Goodness
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Isolation and Characterization of Donor-Derived Exosomes in Human Lung Transplantation
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Allograft Rejection; Allorecognition; Biomarkers; Bronchoalveolar Lavage; Ex Vivo Lung Perfusate; Exosomes; Lung Transplantation; Primary Graft Dysfunction; Therapeutic; Transplant Immunology
Abstract
Although lung transplantation is the best strategy for the treatment of patients with lung failure, post-transplant survival is limited to a median of 6 years. This is largely due to the development of chronic lung allograft dysfunction (CLAD), a condition resulting from the body's attack on the foreign donor lung. Because current treatment strategies for CLAD are minimally effective and are associated with numerous side effects, there is need for better therapeutic options. To resolve this need, my study aims at enhancing our understanding of the mechanism underlying the development of CLAD through the analysis of exosomes. Exosomes are small fluid-filled sacs released by most cells of the body. They contain proteins and other molecules that carry information from their cell of origin to neighboring cells. In particular, immune cells responsible for fighting off bacteria and foreign objects in the body release exosomes containing proteins involved in immune activation. This activation could in turn increase the production of exosomes, thus perpetuating injury. Therefore, I predict that exosomes released by donor lungs are present in recipients, and they stimulate immune response which leads to CLAD. To test this, I will isolate and identify donor exosomes from three biological fluids: wash of donor lung outside the body, wash of donor lung after transplantation, and patient’s blood. Then, I will analyze the quantity and quality of donor exosomes in each body fluid, and see how these correlate with patient outcome. If CLAD patients present with an altered donor exosome profile compared to stable patients, then this suggests that exosomes may play a role in CLAD development, and treatments strategies may be adjusted accordingly.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Madu, Goodness
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~